Replies to post #140 on Ocular Therapeutix Inc (OCUL)

[The Rainmaker]

Dane Leone, BTIG - Analyst [49]

--------------------------------------------------------------------------------

Okay. And just a last point on that is has something, since you called out the Regeneron partnership in the press release and on the call here, did something specifically progress forward in that development pathway over the last three months or since your last update?

--------------------------------------------------------------------------------

Amar Sawhney, Ocular Therapeutix, Inc. - President, CEO & Chairman [50]

--------------------------------------------------------------------------------

So it's hard for us to comment given that this is something that we have to collaboratively speak about. So we cannot make unilateral statements.

All I would say is that the relationship is progressing nicely. And they are continue to be very enthused about the progress that is being made and we have provided them with product candidates that they are in the process of testing and feel that that's going in the right direction.